Ticker Scorecard - INVA Basics Company: Innoviva, Inc. IPO Date: November 25, 2008 Sector: Healthcare Industry: Pharma Market Cap: $1.13B Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 1.48% Avg Daily Range (30 D): $0.13 | 0.74% Avg Daily Range (90 D): $0.15 | 0.80% Institutional Daily Volume Avg Daily Volume: .64M Avg Daily Volume (30 D): .37M Avg Daily Volume (90 D): .41M Trade Size Avg Trade Size (Sh.): 100 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 4,106 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $2.03M Avg Inst. Trade (90 D): $2.6M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.67M Avg Closing Trade (30 D): $1.64M Avg Closing Trade (90 D): $2.12M Avg Closing Volume: 117.05K     News Dec 16, 2024 @ 6:15 AM Basilea announces agreement with Innoviva Specialt... Source: N/A Jun 18, 2024 @ 5:44 PM Analyst Projects Strong Growth for GSK-Innoviva Pa... Source: Vandana Singh Mar 2, 2024 @ 3:29 PM 10 stocks you can bet on being inflation-proof Source: MarketWatch May 24, 2023 @ 2:32 AM FDA approves Innoviva’s bacterial pneumonia... Source: MarketWatch May 16, 2023 @ 1:08 PM Over $125M Bet On Occidental Petroleum? Check Out ... Source: Lisa Levin Financials   TTM Q2 2024 Q1 2024 Basic EPS $.02 $-.55 $.58 Diluted EPS $.02 $-.55 $.46 Revenue $ 89.51M $ 99.9M $ 77.5M Gross Profit $ $ $ Net Income / Loss $ 1.21M $ -34.69M $ 36.53M Operating Income / Loss $ 6.85M $ -39.28M $ 45.12M Cost of Revenue $ $ $ Net Cash Flow $ 43.63M $ 38.65M $ -15.16M PE Ratio 904.00     Splits Jun 17, 2013:   100:1